Metraipolis › archive › dc_2eeaeee7a289
Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform — Europe PMC PMID:41611660
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41611660
- DOI
- 10.1038/s41392-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T10:27:59.557Z
- SHA-256 of the archived text
a21bdb5680ab6a0bec28d93094d760993f94ccb6cac4e09765fa3d434928e7a9- Stable URL of this page
https://metraipolis.com/documento/dc_2eeaeee7a289
How to cite
Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform — Europe PMC PMID:41611660 — Europe PMC (en), https://europepmc.org/article/MED/41611660 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eeaeee7a289 (Metraipolis archive dc_2eeaeee7a289, sha256 a21bdb5680ab6a0bec28d93094d760993f94ccb6cac4e09765fa3d434928e7a9)
BibTeX
@misc{dc2eeaeee7a289,
title = {Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform — Europe PMC PMID:41611660},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41611660},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eeaeee7a289; sha256 a21bdb5680ab6a0bec28d93094d760993f94ccb6cac4e09765fa3d434928e7a9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41611660. Agents can read the archived copy with the MCP tool read_document.